tetrabromobisphenol a has been researched along with gw9662 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajta, M; Szychowski, KA; Wojtowicz, AK | 1 |
| Honkisz, E; Wójtowicz, AK | 1 |
2 other study(ies) available for tetrabromobisphenol a and gw9662
| Article | Year |
|---|---|
PPAR-γ agonist GW1929 but not antagonist GW9662 reduces TBBPA-induced neurotoxicity in primary neocortical cells.
Topics: Anilides; Animals; Apoptosis; Benzophenones; Caspase 3; Cells, Cultured; Central Nervous System Agents; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Mice; Neocortex; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Polybrominated Biphenyls; PPAR gamma; Time Factors; Tyrosine | 2014 |
The role of PPARγ in TBBPA-mediated endocrine disrupting effects in human choriocarcinoma JEG-3 cells.
Topics: Anilides; Apoptosis; Benzophenones; Caspase 3; Cell Line; Cell Survival; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Endocrine Disruptors; Female; Humans; Placenta; Polybrominated Biphenyls; PPAR gamma; Pregnancy; Progesterone; Tyrosine; Uterine Neoplasms | 2015 |